Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Healthcare Medical Devices

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

TSXV:ADK - Post by User

Diagnos Inc

Bullboard Posts

Comment by whippeton Jan 12, 2017 9:36am

102 Views

Post# 25698517

RE:RE:RE:RE:Bayer+DIAGNOS VS Google

ADK is a little company with great advantages.... technology, vision, good partnerships. But what it does not have yet is deep pockets, or willingness to have those partners invest in the stock to help the company be strong and move faster to the next level. A Bayer or a Novartis should hold around 10% of the company. If not, they will lose to Google the edge they might have right now.
one thing is for sure.... our stock price and value is a joke at these levels. what's great is that the sellers dont know what they're selling, and we can take advantage of it.

please DYOD and enjoy the ride in the coming months.

Bullboard Posts

Changing Europe’s dependency on HREE from China